Companies / Japan
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Speculation Links Astellas, Serono
March 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Reports in the international media have prompted Astellas, Japan's third-largest drugmaker, to deny claims that the company is to use a US$8.6bn loan to acquire Swiss biotech Serono. However, officials at both companies have refused to comment further. Serono has been seeking a buyer since November 2005, but the interest of multinationals including GSK is reported to have waned in recent